AI vaccine shows limited efficacy
A study from the University of Cambridge showed that an innovative vaccine utilizing artificial intelligence did not produce tangible results in boosting immunity among approximately thirty people who received it. Despite the disappointing outcomes, this is the first of its kind to be developed entirely by algorithms based on the genetic data of coronavirus variants, aiming to predict future virus evolutions and reduce the need for regular vaccine updates.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)